DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,198,478 | -0.5% | 198,301 | -3.7% | 0.32% | +5.6% |
| Q2 2023 | $49,444,320 | -2.4% | 206,018 | +2.5% | 0.30% | -9.3% |
| Q1 2023 | $50,647,438 | -4.6% | 200,950 | +0.5% | 0.33% | -10.2% |
| Q4 2022 | $53,086,389 | +0.5% | 200,009 | -2.2% | 0.37% | -3.4% |
| Q3 2022 | $52,812,000 | +0.7% | 204,466 | -1.1% | 0.38% | +8.2% |
| Q2 2022 | $52,422,000 | -14.3% | 206,775 | -0.9% | 0.36% | +6.0% |
| Q1 2022 | $61,202,000 | -12.9% | 208,647 | -2.3% | 0.34% | -4.6% |
| Q4 2021 | $70,267,000 | +2.8% | 213,570 | -4.8% | 0.35% | -3.6% |
| Q3 2021 | $68,331,000 | +7.1% | 224,448 | -5.6% | 0.36% | +68.5% |
| Q2 2021 | $63,805,000 | +14.5% | 237,759 | -4.0% | 0.22% | +10.2% |
| Q1 2021 | $55,745,000 | -1.6% | 247,667 | -2.9% | 0.20% | -6.7% |
| Q4 2020 | $56,672,000 | +1.8% | 255,120 | -1.3% | 0.21% | -21.3% |
| Q3 2020 | $55,653,000 | +17.9% | 258,453 | -3.1% | 0.27% | +17.1% |
| Q2 2020 | $47,185,000 | +32.2% | 266,837 | +3.5% | 0.23% | +16.3% |
| Q1 2020 | $35,694,000 | -4.9% | 257,883 | +5.5% | 0.20% | +35.2% |
| Q4 2019 | $37,525,000 | +8.4% | 244,494 | +2.0% | 0.14% | +3.6% |
| Q3 2019 | $34,608,000 | +1.6% | 239,621 | +0.6% | 0.14% | +5.3% |
| Q2 2019 | $34,052,000 | -8.1% | 238,259 | -15.1% | 0.13% | -5.7% |
| Q1 2019 | $37,070,000 | +29.1% | 280,792 | +0.8% | 0.14% | +19.5% |
| Q4 2018 | $28,718,000 | -11.1% | 278,488 | -6.3% | 0.12% | +10.3% |
| Q3 2018 | $32,307,000 | +15.9% | 297,323 | +5.3% | 0.11% | +10.3% |
| Q2 2018 | $27,874,000 | +0.5% | 282,473 | -0.3% | 0.10% | 0.0% |
| Q1 2018 | $27,739,000 | -2.8% | 283,314 | -7.9% | 0.10% | +3.2% |
| Q4 2017 | $28,542,000 | +11.2% | 307,493 | +2.7% | 0.09% | +3.3% |
| Q3 2017 | $25,672,000 | -3.4% | 299,281 | -5.0% | 0.09% | -4.2% |
| Q2 2017 | $26,586,000 | -1.0% | 315,033 | +0.3% | 0.10% | -3.1% |
| Q1 2017 | $26,859,000 | +20.6% | 314,034 | +9.7% | 0.10% | +14.0% |
| Q4 2016 | $22,280,000 | -99.9% | 286,227 | -0.1% | 0.09% | -3.4% |
| Q3 2016 | $22,467,671,000 | -21.7% | 286,614 | +0.9% | 0.09% | -25.8% |
| Q2 2016 | $28,695,009,000 | +6.5% | 284,109 | +0.0% | 0.12% | +14.3% |
| Q1 2016 | $26,950,000,000 | -9.2% | 284,095 | -11.1% | 0.10% | -13.9% |
| Q4 2015 | $29,687,000,000 | +111237.4% | 319,627 | +2.1% | 0.12% | +5.2% |
| Q3 2015 | $26,664,000 | -99.9% | 312,924 | -4.1% | 0.12% | +3.6% |
| Q2 2015 | $27,930,841,000 | +1.9% | 326,333 | +1.0% | 0.11% | -0.9% |
| Q1 2015 | $27,419,559,000 | +8.0% | 322,963 | +9.1% | 0.11% | +2.7% |
| Q4 2014 | $25,380,016,000 | +5.9% | 296,115 | -6.1% | 0.11% | +3.8% |
| Q3 2014 | $23,971,157,000 | -1.8% | 315,493 | +1.8% | 0.11% | -1.9% |
| Q2 2014 | $24,404,489,000 | +13.3% | 309,977 | +7.9% | 0.11% | +6.9% |
| Q1 2014 | $21,540,375,000 | +7.6% | 287,205 | +10.7% | 0.10% | +5.2% |
| Q4 2013 | $20,021,434,000 | +11.5% | 259,345 | +0.1% | 0.10% | -2.0% |
| Q3 2013 | $17,956,098,000 | +10.9% | 259,032 | +1.3% | 0.10% | +1.0% |
| Q2 2013 | $16,185,430,000 | – | 255,694 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |